← Back
Orthopediatrics
KIDS · listed on Nasdaq · worth $565.28 million
$30.80
+29.30% on Oct 28
No insider bought Orthopediatrics stock in the last year. They sold it 18 times, $38.46 million in all.
Red dot = an insider sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
18.2M shares
70% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, three insiders sold Orthopediatrics stock and none bought. None of the 18 sales is marked on its filing as planned in advance. The biggest seller was Squadron Capital LLC.
Planned sales
Form 144 notices filed for Orthopediatrics in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
10% holder Squadron Capital LLC filed to sell 700,000 shares on 24 Aug; sold 700,000 by 10 SepNotice on SEC.gov
Big investors
People and funds that reported owning 5% or more of Orthopediatrics, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateSquadron Capital LLC23.8%Sep 11Reported stake, oldest first: 25.0% (Sep 1) → 23.8% (Sep 11)
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateSquadron Capital LLC25.0%Sep 1
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for Orthopediatrics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Sep 11SoldJennifer N. PritzkerSep 11 · Traded Sep 10 · 10% ownervia a trust or family302,369 @ $21.01$6.35M
Sep 4SoldJennifer N. PritzkerSep 4 · Traded Sep 2 · 10% ownervia a trust or family22,500 @ $23.35$525.4K
14 more with Pro →Analysts, earnings and news
Analysts' price target
$24.67 average
9 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q1 '26−$0.42 a share+$0.02
Q4 '25−$0.26 a share+$0.03
Q3 '25−$0.24 a share+$0.02
Q2 '25−$0.11 a share+$0.17